CLINICAL_TRIALS
trial_result
· 2023-03-23
Clinical Trial Update: Dymista Allergen Chamber - Onset of Action Study [Phase 4]
Summary
Phase 4 clinical trial update for Dymista in seasonal allergic rhinitis; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Seasonal Allergic Rhinitis | Phase 4 | Status: COMPLETED | Results posted: 2023-03-23